GURGAON, INDIA, September 12, 2013 /24-7PressRelease/ -- Medanta the Medicity, one of the World Class Hospital in India exists primarily to serve the community. The Medical Institute was created to the highest standards of medical care along with clinical research, education, and training. Medanta was founded by cardiac surgeon Dr. Naresh Trehan with the aim to make it the Best Medical Institution in India. From time to time Medanta holds several workshops and seminars to propagate its new researches in diagnosis as well as treatment of the diseases. This institute provides high commitment towards personal health to avoid illness and provide wellness.

Medanta would hold a programme on Cancer Prostate on 14 September 2013 as it's becoming the second most common cancer in males. With the increase in longevity & awareness, the number of patients of cancer prostate is increasing every year. There is also stage migration and early diagnosis in younger population. This increases the responsibility of the treating doctors for proper planning and management so that cancer prostate patients can have prolonged survival with good quality of life. Thus, Medanta is planning to come up with this programme which would help in propagating their experience as well as other developments.

During the last 2 decades, there are significant advances in areas of diagnosis, biomarkers, imaging, risk stratification, robotic surgery, radiation techniques, chemotherapy, immunotherapy, targeted therapy etc in the management of cancer prostate. This update is planned to cover all these aspects and share our experience. The programme is aimed for physicians, surgeons, urologists, radiation and medical oncologist, radiologist and pathologist who are involved in management of cancer prostate. The faculty consists of experts in various specilities with vast experience from Delhi and NCR.

So, Medanta being one of the Top Medical Institutions in India is working diligently for the prevention of any critical disease. It provides early diagnosis and treatment of common disorders as well as indulges in regular research for advances in treatment of critical diseases.